Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.39 |
| ▸ | KDM1A | O60341 | 6/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.37 |
| ▸ | KDM1B | Q8NB78 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29710388 | 1.00 | AHR (0.39) | AHRKDM1AKCNH2KDM1BCA1 | |
| SCHEMBL28157241 | 0.85 | KDM1A (0.44) | AHRKDM1AKCNH2KDM1BCA1 | |
| SCHEMBL345490 | 0.85 | KDM1A (0.44) | KDM1AKCNH2KDM1BCA1CA2 | |
| SCHEMBL29365213 | 0.85 | KDM1A (0.44) | KDM1AKCNH2KDM1BCA1CA2 | |
| SCHEMBL505780 | 0.83 | KDM1A (0.48) | AHRKDM1AKCNH2KDM1BCA1 | |
| SCHEMBL13451436 | 0.82 | GPR84 (0.35) | AHRCA1CA2CA9 | |
| SCHEMBL345437 | 0.82 | KDM1A (0.43) | KDM1AKCNH2KDM1BCA1CA2 | |
| SCHEMBL734289 | 0.79 | KDM1A (0.32) | KDM1AKCNH2KDM1BGAAMAPT | |
| SCHEMBL3753430 | 0.77 | CA1 (0.32) | KDM1AKCNH2KDM1BCA1CA2 | |
| SCHEMBL3150379 | 0.77 | CA1 (0.32) | KDM1AKCNH2KDM1BCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617793-B2 | Organic electron transfer mediator and device comprising same | I-SENS, INC. (KR) | 2026-05-05 | — | — | US | claimed |
| CN-117659084-A | Aromatic amine modified tridentate phosphine coordination copper complex, and preparation method and application thereof | 黑龙江大学 | 2024-03-08 | — | — | CN | claimed |
| CN-116514649-A | Preparation method of 4, 5-difluorophthalic acid | 河南省科学院化学研究所有限公司 | 2023-08-01 | — | — | CN | claimed |
| US-20230102721-A1 | NOVEL ORGANIC ELECTRON TRANSFER MEDIATOR AND DEVICE COMPRISING SAME | I-SENS, INC. (KR) | 2023-03-30 | — | — | US | claimed |
| EP-4083043-A1 | NOVEL ORGANIC ELECTRON TRANSFER MEDIATOR AND DEVICE COMPRISING SAME | I-SENS, INC. (KR) | 2022-11-02 | — | — | EP | claimed |
| CN-114981271-A | Novel organic electron transfer mediator and device comprising same | 爱-森新株式会社 | 2022-08-30 | — | — | CN | claimed |
| CN-112707807-B | Preparation method of 4, 5-difluorophthalic acid | 苏州当量生物医药有限公司 | 2022-06-07 | — | — | CN | claimed |
| EP-3452471-B1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-12-08 | — | — | EP | claimed |
| CN-109071501-B | Organic molecules, in particular for organic opto-electronic devices | 辛诺拉有限公司 | 2021-07-09 | — | — | CN | claimed |
| WO-2021133144-A1 | NOVEL ORGANIC ELECTRON TRANSFER MEDIATOR AND DEVICE COMPRISING SAME | 주식회사 아이센스 | 2021-07-01 | — | — | WO | claimed |
| CN-112707807-A | Preparation method of 4, 5-difluorophthalic acid | 苏州金蚕新材料科技有限公司 | 2021-04-27 | — | — | CN | claimed |
| CN-108276445-B | Thermal excitation delayed fluorescence main body material and preparation and application thereof | 黑龙江大学 | 2020-03-31 | — | — | CN | claimed |
| EP-3452471-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-03-13 | — | — | EP | claimed |
| US-7173155-B1 | Terphenyl dihalide monomers having sulfonate groups and process for preparing the same | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2007-02-06 | — | — | US | claimed |
| US-12617793-B2 | Organic electron transfer mediator and device comprising same | I-SENS, INC. (KR) | 2026-05-05 | — | — | US | disclosed |
| US-20260028531-A1 | Liquid Crystalline Compounds | MERCK PATENT GMBH (DE) | 2026-01-29 | — | — | US | disclosed |
| EP-4685208-A1 | LIQUID CRYSTALLINE COMPOUNDS | Merck Patent GmbH (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-5739166-A | ALKYLSULFONYL OR AMINOSULFONYL SUBSTITUTED AROMATIC COMPOUNDS AS NON-STEROIDAL ANTIINFLAMMATORY AGENT | G.D. SEARLE & CO. (US) | 1998-04-14 | — | — | US | disclosed |
| EP-0794942-A1 | SUBSTITUTED BIPHENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-09-17 | — | — | EP | disclosed |
| WO-1996016934-A1 | SUBSTITUTED BIPHENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-06-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617793-B2 | Organic electron transfer mediator and device comprising same | SCO2, ETFB, MT-CO1 | AHR 1569/4885KDM1A 1721/4885KCNH2 1116/4885 |
| US-20260028531-A1 | Liquid Crystalline Compounds | POU2F1, FES, POU2F2 | AHR 3068/4885KDM1A 3482/4885KCNH2 235/4885 |
| US-20230102721-A1 | NOVEL ORGANIC ELECTRON TRANSFER MEDIATOR AND DEVICE COMPRISING SAME | MT-ND4, MT-ND2, SLC25A21 | AHR 2526/4885KDM1A 1557/4885KCNH2 1463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.